NCT03228537 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 28
- units
- Participants
- groups
- description
- NEOADJUVANT: Patients receive atezolizumab IV over 30-60 minutes, pemetrexed disodium IV over 10 minutes, and cisplatin IV over 2 hours on day 1. Cycles repeats every 21 days for 4 cycles in the absence of disease progression or unexpected toxicity. SURGERY: Within 21-90 days after completion of neoadjuvant therapy, patients undergo extrapleural pneumonectomy (EPP) or pleurectomy/decortication (PD). Patients who undergo EPP will then undergo radiation therapy. MAINTENANCE: Within 90 days after completion of either PD or radiation (post-EPP), patients receive atezolizumab IV over 60 minutes on day 1. Treatment repeats every 21 days for up to 1 year in the absence of disease progression or unexpected toxicity.
- id
- BG000
- title
- Treatment (Chemotherapy, Surgery +/- RT, Maintenance)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 31.5
- upper Limit
- 77.3
- value
- 68.1
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Female
- measurements
- group Id
- BG000
- value
- 20
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 27
- title
- No
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- title
- Hispanic
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- title
- White
- measurements
- group Id
- BG000
- value
- 3
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Extrapleural Pneumonectomy (EPP)
- measurements
- group Id
- BG000
- value
- 24
- title
- Pleurectomy/Decortication (PD)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Surgery
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- title
- 0
- measurements
- group Id
- BG000
- value
- 13
- title
- 1
- description
- Performance Status uses the Zubrod Scale as follows: 0 - Fully active, able to carry on all pre-disease performance w/o restriction 1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 23
- title
- <6%
- measurements
- group Id
- BG000
- value
- 4
- title
- 5-<10%
- measurements
- group Id
- BG000
- value
- 1
- title
- Pending
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Weight Loss Past 6 Months
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 22
- title
- Measurable
- measurements
- group Id
- BG000
- value
- 6
- title
- Not Assessable
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Baseline Disease Status mRECIST
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 14
- title
- Measurable
- measurements
- group Id
- BG000
- value
- 14
- title
- Non-Measurable
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Baseline Disease Status RECIST
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 28
- units
- Participants
- groups
- description
- NEOADJUVANT: Patients receive atezolizumab IV over 30-60 minutes, pemetrexed disodium IV over 10 minutes, and cisplatin IV over 2 hours on day 1. Cycles repeats every 21 days for 4 cycles in the absence of disease progression or unexpected toxicity. SURGERY: Within 21-90 days after completion of neoadjuvant therapy, patients undergo extrapleural pneumonectomy (EPP) or pleurectomy/decortication (PD). Patients who undergo EPP will then undergo radiation therapy. MAINTENANCE: Within 90 days after completion of either PD or radiation (post-EPP), patients receive atezolizumab IV over 60 minutes on day 1. Treatment repeats every 21 days for up to 1 year in the absence of disease progression or unexpected toxicity.
- id
- BG000
- title
- Treatment (Chemotherapy, Surgery +/- RT, Maintenance)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 31.5
- upper Limit
- 77.3
- value
- 68.1
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Female
- measurements
- group Id
- BG000
- value
- 20
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 27
- title
- No
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- title
- Hispanic
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- title
- White
- measurements
- group Id
- BG000
- value
- 3
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Extrapleural Pneumonectomy (EPP)
- measurements
- group Id
- BG000
- value
- 24
- title
- Pleurectomy/Decortication (PD)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Surgery
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- title
- 0
- measurements
- group Id
- BG000
- value
- 13
- title
- 1
- description
- Performance Status uses the Zubrod Scale as follows: 0 - Fully active, able to carry on all pre-disease performance w/o restriction 1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 23
- title
- <6%
- measurements
- group Id
- BG000
- value
- 4
- title
- 5-<10%
- measurements
- group Id
- BG000
- value
- 1
- title
- Pending
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Weight Loss Past 6 Months
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 22
- title
- Measurable
- measurements
- group Id
- BG000
- value
- 6
- title
- Not Assessable
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Baseline Disease Status mRECIST
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 14
- title
- Measurable
- measurements
- group Id
- BG000
- value
- 14
- title
- Non-Measurable
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Baseline Disease Status RECIST
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle